We are live on ! Find out more
Hudson Bay Capital Management

Hudson Bay Capital Management Portfolio holdings

AUM $29B
1-Year Est. Return 30.2%
This Fund
S&P 500
This Quarter Est. Return
+5.76%
1 Year Est. Return
+30.2%
3 Year Est. Return
+99.99%
5 Year Est. Return
+135.78%
10 Year Est. Return
+498.47%
AUM
$21.3B
AUM Growth
+$3.22B
Cap. Flow
+$495M
Cap. Flow %
2.33%
Top 10 Hldgs %
36.98%
Holding
1,022
New
305
Increased
151
Reduced
161
Closed
262

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$312M
2
DLTR icon
Dollar Tree
DLTR
+$295M
3
BN icon
Brookfield
BN
+$272M
4
AMZN icon
Amazon
AMZN
+$229M
5
FLG
Flagstar Bank National Association
FLG
+$209M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$686M
2
PXD
Pioneer Natural Resource Co.
PXD
+$309M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$259M
4
TSLA icon
Tesla
TSLA
+$249M
5
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$220M

Sector Composition

Rank Sector Weight
1 Technology 18.59%
2 Consumer Discretionary 8.12%
3 Healthcare 6.81%
4 Financials 5.18%
5 Industrials 2.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORGN
626
DELISTED
Origin Materials
ORGN
$424K ﹤0.01%
15,690
-1,889
-11% -$50.5K
CLRB icon
627
Cellectar Biosciences
CLRB
$21.1M
$375K ﹤0.01%
5,000
– –
TVTX icon
628
Travere Therapeutics
TVTX
$5.68B
$366K ﹤0.01%
+44,561
New +$300K
COHR icon
629
Coherent
COHR
$64.3B
$362K ﹤0.01%
5,000
-10,000
-67% -$601K
RXRX icon
630
Recursion Pharmaceuticals
RXRX
$1.8B
$338K ﹤0.01%
45,000
+15,000
+50% +$131K
PM icon
631
Philip Morris
PM
$290B
$335K ﹤0.01%
+3,309
New +$324K
ALT icon
632
CALL
Altimmune
ALT
$583M
$333K ﹤0.01%
+50,000
New +$369K
NXTC icon
633
NextCure
NXTC
$30.8M
$324K ﹤0.01%
16,983
– –
IGMS
634
DELISTED
IGM Biosciences
IGMS
$317K ﹤0.01%
+46,119
New +$395K
JWN
635
DELISTED
Nordstrom
JWN
$295K ﹤0.01%
+13,884
New +$283K
SG icon
636
PUT
Sweetgreen
SG
$642M
$280K ﹤0.01%
9,300
-13,700
-60% -$376K
SIMO icon
637
Silicon Motion
SIMO
$7.6B
$277K ﹤0.01%
3,416
-57,746
-94% -$4.51M
EAF icon
638
GrafTech
EAF
$206M
$269K ﹤0.01%
+27,713
New +$426K
SONY icon
639
Sony
SONY
$138B
$264K ﹤0.01%
+15,550
New +$257K
ELTX icon
640
Elicio Therapeutics
ELTX
$79.6M
$200K ﹤0.01%
+48,720
New +$412K
LUNRW
641
DELISTED
Intuitive Machines, Inc. Warrants
LUNRW
$198K ﹤0.01%
292,778
+42,778
+17% +$45.2K
AMZN icon
642
CALL
Amazon
AMZN
$2.94T
$193K ﹤0.01%
1,000
-20,000
-95% -$3.67M
STRO icon
643
Sutro Biopharma
STRO
$415M
$178K ﹤0.01%
+6,076
New +$240K
WKHS icon
644
Workhorse Group
WKHS
$34.1M
$164K ﹤0.01%
704
– –
APVO icon
645
Aptevo Therapeutics
APVO
$6.28M
$153K ﹤0.01%
+38
New +$567K
XFOR icon
646
X4 Pharmaceuticals
XFOR
$424M
$132K ﹤0.01%
+7,575
New +$248K
ZURA icon
647
Zura Bio
ZURA
$531M
$122K ﹤0.01%
38,999
– –
MAXN
648
CALL
DELISTED
Maxeon Solar Technologies
MAXN
$80.5K ﹤0.01%
+944
New +$200K
ZURAW
649
DELISTED
Zura Bio Limited Warrants
ZURAW
$79.8K ﹤0.01%
199,575
-400
-0.2% -$203
MGX icon
650
Metagenomi Therapeutics
MGX
$45.7M
$69.4K ﹤0.01%
17,000
-49,666
-74% -$341K
24 25
26
27 28

Similar funds

Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
State of Tennessee, Department of Treasury
State of Tennessee, Department of Treasury Nashville, Tennessee $29.8B AUM 29.48% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Eagle Capital Management (New York)
Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
TWC
The Woodbridge Company Toronto, Ontario, Canada $27.8B AUM 46.78% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Hudson Bay Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Hudson Bay Capital Management held 1,022 positions worth $21.3B, up 18% from $18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Hudson Bay Capital Management's Q2 2024 filing shows 305 new, 151 increased, 161 reduced and 262 closed positions. Its largest new stake was Eli Lilly: 390,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $686M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Hudson Bay Capital Management's largest Q2 2024 buy was Eli Lilly: 390,000 shares worth $353M.
  • Hudson Bay Capital Management added most to Amazon in Q2 2024, an estimated $229M increase.
  • Hudson Bay Capital Management's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $686M.
  • Hudson Bay Capital Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $309M.
  • Hudson Bay Capital Management's ten largest holdings make up 37% of its $21.3B portfolio in Q2 2024.
  • Hudson Bay Capital Management opened 305 new positions and closed 262 in Q2 2024.
  • Hudson Bay Capital Management's portfolio value rose 18% quarter-over-quarter to $21.3B.

Based on Hudson Bay Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.